Next-generation Sequencing
8
3
4
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
12.5%
1 terminated out of 8 trials
0.0%
-86.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (8)
Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients
Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer
Taiwan Associated Genetic and Nongenetic Small Vessel Disease
Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)
Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION)
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC
Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases